Page last updated: 2024-09-03

2,4,5-trihydroxyamphetamine and 5-amino-2,4-dihydroxy-alpha-methylphenylethylamine

2,4,5-trihydroxyamphetamine has been researched along with 5-amino-2,4-dihydroxy-alpha-methylphenylethylamine in 1 studies

Compound Research Comparison

Studies
(2,4,5-trihydroxyamphetamine)
Trials
(2,4,5-trihydroxyamphetamine)
Recent Studies (post-2010)
(2,4,5-trihydroxyamphetamine)
Studies
(5-amino-2,4-dihydroxy-alpha-methylphenylethylamine)
Trials
(5-amino-2,4-dihydroxy-alpha-methylphenylethylamine)
Recent Studies (post-2010) (5-amino-2,4-dihydroxy-alpha-methylphenylethylamine)
7001000

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bennett, J; Cohenour, P; Enwall, EL; Kostrzewa, R; Lehr, RE; Lewis, RJ; Lin, L; Lin, PY; Ma, S; Raghavan, R1

Other Studies

1 other study(ies) available for 2,4,5-trihydroxyamphetamine and 5-amino-2,4-dihydroxy-alpha-methylphenylethylamine

ArticleYear
In vivo and in vitro studies on the neurotoxic potential of 6-hydroxydopamine analogs.
    Journal of medicinal chemistry, 1995, Sep-29, Volume: 38, Issue:20

    Topics: Animals; Brain; Brain Chemistry; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred ICR; Neurotransmitter Agents; Oxidopamine; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship

1995